Literature DB >> 18809687

Two active forms of Zymomonas mobilis levansucrase. An ordered microfibril structure of the enzyme promotes levan polymerization.

Dan Goldman1, Noa Lavid, Alon Schwartz, Gil Shoham, Dganit Danino, Yuval Shoham.   

Abstract

Fructansucrases, members of glycoside hydrolase family 68, catalyze both sucrose hydrolysis and the polymerization of fructose to beta-d-fructofuranose polymers. The resulting fructan polymers are distinguished by the nature of the glycosidic bond: inulin (beta-(2-1)-fructofuranose) and levan (beta-(2-6)-fructofuranose). In this study we demonstrate that Zymomonas mobilis levansucrase exists in two active forms, depending on the pH and ionic strength. At pH values above 7.0, the enzyme is mainly a dimer, whereas at pH values below 6.0, the protein forms well ordered microfibrils that precipitate out of the solution. These two forms are readily interchangeable simply by changing the pH. Surprisingly the manner in which the enzyme is arranged strongly affects its product specificity and kinetic properties. At pH values above 7.0, the activity of the enzyme as a dimer is mainly sucrose hydrolysis and the synthesis of short fructosaccharides (degree of polymerization, 3). At pH values below 6.0, in its microfibril form, the enzyme catalyzes almost exclusively the synthesis of levan (a degree of polymerization greater than 20,000). This difference in product specificity appears to depend on the form of the enzyme, dimer versus microfibril, and not directly on the pH. Images made by negative stain transmission electron microscopy reveal that the enzyme forms a very ordered structure of long fibrils that appear to be composed of repeating rings of six to eight protein units. A single amino acid replacement of H296R abolished the ability of the enzyme to form microfibrils with organized fibril networks and to synthesize levan at pH 6.0.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18809687     DOI: 10.1074/jbc.M805985200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Cloning, expression, purification, crystallization and preliminary X-ray analysis of EaLsc, a levansucrase from Erwinia amylovora.

Authors:  Lorenzo Caputi; Michele Cianci; Stefano Benini
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-04-30

2.  Replica exchange molecular dynamics simulations reveal the structural and molecular properties of levan-type fructo-oligosaccharides of various chain lengths.

Authors:  Pongsakorn Kanjanatanin; Rath Pichyangkura; Surasak Chunsrivirot
Journal:  BMC Bioinformatics       Date:  2016-08-17       Impact factor: 3.169

3.  Unraveling the structural and molecular properties of 34-residue levans with various branching degrees by replica exchange molecular dynamics simulations.

Authors:  Surasak Chunsrivirot; Pongsakorn Kanjanatanin; Rath Pichyangkura
Journal:  PLoS One       Date:  2018-08-21       Impact factor: 3.240

4.  Novel fructan exohydrolase: unique properties and applications for human health.

Authors:  Wim Van den Ende
Journal:  J Exp Bot       Date:  2018-08-14       Impact factor: 6.992

5.  Insights into the pH-dependent, extracellular sucrose utilization and concomitant levan formation by Gluconobacter albidus TMW 2.1191.

Authors:  Frank Jakob; Clara Gebrande; Regina M Bichler; Rudi F Vogel
Journal:  Antonie Van Leeuwenhoek       Date:  2020-03-04       Impact factor: 2.271

6.  Product-oriented chemical surface modification of a levansucrase (SacB) via an ene-type reaction.

Authors:  Maria Elena Ortiz-Soto; Julia Ertl; Jürgen Mut; Juliane Adelmann; Thien Anh Le; Junwen Shan; Jörg Teßmar; Andreas Schlosser; Bernd Engels; Jürgen Seibel
Journal:  Chem Sci       Date:  2018-05-22       Impact factor: 9.825

7.  Molecular dynamics provides insight into how N251A and N251Y mutations in the active site of Bacillus licheniformis RN-01 levansucrase disrupt production of long-chain levan.

Authors:  Thassanai Sitthiyotha; Rath Pichyangkura; Surasak Chunsrivirot
Journal:  PLoS One       Date:  2018-10-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.